🇺🇸 FDA
Patent

US 7465449

Anti-αvβ6 antibodies

granted A61KA61K2039/505A61K47/68

Quick answer

US patent 7465449 (Anti-αvβ6 antibodies) held by The Regents of the University of California expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
58
CPC classes
A61K, A61K2039/505, A61K47/68, A61K47/6835, A61K47/6849